SEC Filing Analysis: Invivyd, Inc. (IVVD)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Director Ian Sheffield was granted 100,000 stock options at an exercise price of $0.9549 as standard board compensation.
• Market Impact: Neutral; standard compensation event with minimal dilution.

Company Information

Field	Value
Company	Invivyd, Inc.
Ticker Symbol	IVVD
CIK	0001832038
Industry	Biological Products (No Diagnostic Substances)

Insider Information

Field	Value
Name	Sheffield Ian
CIK	0001594410
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-08-31
Transaction Code	A (Award/Grant)
Security Type	Stock Option (Right to Buy)
Shares Involved	100,000
Price Per Share	$0.00 (Exercise Price: $0.9549)
Total Value	$0.00
Shares Owned After	100,000
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0.00 (Option Grant)
% of Market Cap	0.00%
Shares Transacted	100,000
% of Shares Outstanding	0.034%
Post-Transaction Ownership	100,000 derivative shares (0.034% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Across Invivyd's $0.29B market capitalization, this option award represents a negligible fraction of equity value.
• Dilution Impact: 100,000 option shares represent approximately 0.034% of the 294.61M shares outstanding, posing negligible dilution risk.
• Transaction Significance: Low significance; standard director compensation vesting over a 3-year period (1/3 after year one, remainder monthly over 24 months).

Market Impact Analysis

• Direction: Neutral
• Reasoning: Routine equity grant awarded under corporate incentive plans without open-market buying or selling activity.
• Volume & Sentiment: Neutral impact on trading volume and market sentiment.